LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Reiterates Aprea Therapeutics, Inc. (APRE) At Outperform With $11 Price Target 5/14/2024 3:56:33 PM
  • Aprea Therapeutics Appoints Nadeem Mirza As Chief Medical Officer 5/2/2024 9:28:13 AM
  • Wedbush Is Cutting Aprea Therapeutics, Inc. (APRE) FY24 Estimate To -3.36 From -0.93 3/26/2024 4:54:59 PM
  • Wedbush Is Cutting Aprea Therapeutics, Inc. (APRE) Q4 24 Estimate To -0.93 From -0.26 3/26/2024 4:54:41 PM
  • Wedbush Is Lowering Aprea Therapeutics, Inc. (APRE) Q3 24 Estimate To -0.87 From -0.24 3/26/2024 4:54:27 PM
  • Wedbush Is Cutting Aprea Therapeutics, Inc. (APRE) Q2 24 Estimate To -0.81 From -0.22 3/26/2024 4:54:14 PM
  • Wedbush Is Lowering Aprea Therapeutics, Inc. (APRE) Q1 24 Estimate To -0.75 From -0.20 3/26/2024 4:54:00 PM
  • Aprea Therapeutics Announces Private Placement Financing Of Up To $34.0 Mln; Stock Up In Pre-market 3/11/2024 8:55:22 AM
  • Aprea Therapeutics: FDA Clears IND Application (IND 169359) For APR-1051 3/11/2024 8:37:12 AM
  • Wedbush Is Raising Aprea Therapeutics, Inc. (APRE) FY24 Estimate To -1.13 From -1.86 8/10/2023 4:54:09 PM
  • Wedbush Is Raising Aprea Therapeutics, Inc. (APRE) Q4 24 Estimate To -0.32 From -0.51 8/10/2023 4:53:54 PM
  • Wedbush Is Increasing Aprea Therapeutics, Inc. (APRE) Q3 24 Estimate To -0.29 From -0.48 8/10/2023 4:53:39 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap